en

PRODUCT DETAIL

Erlotinib Sandoz 100 mg

Code 7458C
MA number 44/0118/18-S
Product Form: tbl flm 30x100 mg (blis.Al/OPA/Al/PVC)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EB Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors
L01EB02 Erlotinib
Shelf life: 36
Container: blister Al/OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 26.03.2018
PIL: PIL_Erlotinib Sandoz 100 mg_04.2024.pdf  
SPC: SPC_Erlotinib Sandoz 100 mg_04.2024.pdf  
Safety feature Yes
Data update: 15.04.2024
eu-flag.png sk-flag.png